cbdMD (YCBD) EBIT (2016 - 2025)
Historic EBIT for cbdMD (YCBD) over the last 10 years, with Q3 2025 value amounting to -$685816.0.
- cbdMD's EBIT fell 11664.99% to -$685816.0 in Q3 2025 from the same period last year, while for Sep 2025 it was -$2.2 million, marking a year-over-year increase of 3477.15%. This contributed to the annual value of -$2.2 million for FY2025, which is 3477.16% up from last year.
- cbdMD's EBIT amounted to -$685816.0 in Q3 2025, which was down 11664.99% from -$904686.0 recorded in Q2 2025.
- In the past 5 years, cbdMD's EBIT ranged from a high of -$86272.0 in Q4 2024 and a low of -$33.1 million during Q2 2022
- In the last 5 years, cbdMD's EBIT had a median value of -$1.8 million in 2023 and averaged -$6.5 million.
- Its EBIT has fluctuated over the past 5 years, first plummeted by 132874.11% in 2021, then soared by 9791.97% in 2024.
- Quarter analysis of 5 years shows cbdMD's EBIT stood at -$25.1 million in 2021, then surged by 83.91% to -$4.0 million in 2022, then surged by 73.66% to -$1.1 million in 2023, then soared by 91.91% to -$86272.0 in 2024, then plummeted by 694.95% to -$685816.0 in 2025.
- Its EBIT was -$685816.0 in Q3 2025, compared to -$904686.0 in Q2 2025 and -$485816.0 in Q1 2025.